HOLLYWOOD, Calif., May 9, 2012 /PRNewswire/ -- Medbox, Inc. (Pinksheets: MDBX) (www.medboxinc.com) announced today that the company, through its wholly owned Subsidiary, Prescription Vending Machines, Inc., has upgraded its credit worthiness and corporate stability ratings to top tier status with Dun & Bradstreet Credibility Corp. Dun & Bradstreet is a company that is steeped in tradition, woven into the fiber of corporate America in the credit reporting industry, dating back to 1837.
D&B's proprietary set of key ratings include the PAYDEX® Score, a predictive indicator for paying bills on time; the Financial Stress Score, an indicator of financial stress in the next 12 months; and the Credit Limit Recommendation, which provides guidelines for extending business credit and an overall D&B Rating which addresses the overall assessment of a business.
Medbox, Inc. (DUNS: 93-072-9434) ranked in the top two tiers in every one of the criteria listed above as well as in the 87th percentile in commercial credit score as compared to other businesses nationally.
"With the posting of our latest financials and the recent top-tier rating by D&B, we are setting the stage for what is proving to be our most successful year ever," stated Dr. Bruce Bedrick, CEO of Medbox, Inc.
About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Tokyo and Toronto, and has their corporate headquarters in Los Angeles.
Medbox provides their patented systems, software and consulting services to pharmacies, urgent care centers, clinics, hospitals, and medical groups worldwide.
Medbox, Inc. is a publicly traded company, and is listed on the OTC Board, ticker symbol MDBX.
For mo
'/>"/>
| SOURCE Medbox, Inc. Copyright©2010 PR Newswire. All rights reserved |